HomeGRTX • NASDAQ
Follow
Galera Therapeutics Inc
Previous close
$0.17
Day range
$0.18 - $0.24
Year range
$0.085 - $3.59
Market cap
10.79M USD
Avg Volume
1.69M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.18M | -60.74% |
Net income | -5.59M | 65.49% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.96M | 62.30% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 18.26M | -42.22% |
Total assets | 26.14M | -40.64% |
Total liabilities | 157.33M | 2.68% |
Total equity | -131.18M | — |
Shares outstanding | 54.39M | — |
Price to book | -0.07 | — |
Return on assets | -40.49% | — |
Return on capital | -56.03% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -5.59M | 65.49% |
Cash from operations | -9.92M | 28.90% |
Cash from investing | 3.98M | 43.04% |
Cash from financing | -232.00K | -108.59% |
Net change in cash | -6.17M | 27.08% |
Free cash flow | -10.45M | 9.41% |
About
Founded
2012
Headquarters
Website
Employees
7